Published in Gut on February 01, 2000
Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut (2001) 2.08
Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients. BMC Immunol (2010) 1.73
KRAS mutation and microsatellite instability: two genetic markers of early tumor development that influence the prognosis of colorectal cancer. Ann Surg Oncol (2009) 1.26
Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer. Int J Colorectal Dis (2006) 1.06
The immunogenicity of colorectal cancers with high-degree microsatellite instability. World J Surg Oncol (2005) 1.01
Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis. Br J Cancer (2002) 1.00
Prognostic significance of microsatellite instability in sporadic colorectal cancer. Int J Colorectal Dis (2004) 0.96
Prognosis in DNA mismatch repair deficient colorectal cancer: are all MSI tumours equivalent? Fam Cancer (2004) 0.96
Clinicopathologic features and prognostic analysis of MSI-high colon cancer. Int J Colorectal Dis (2011) 0.88
Relationships of tumor inflammatory infiltration and necrosis with microsatellite instability in colorectal cancers. World J Gastroenterol (2005) 0.83
Replication error phenotype in colorectal cancer. Gut (2000) 0.78
Prognostic values of chromosome 18q microsatellite alterations in stage II colonic carcinoma. World J Gastroenterol (2010) 0.75
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
Genetic alterations during colorectal-tumor development. N Engl J Med (1988) 26.82
Clues to the pathogenesis of familial colorectal cancer. Science (1993) 14.52
Microsatellite instability in cancer of the proximal colon. Science (1993) 14.51
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell (1993) 13.54
Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science (1995) 13.15
Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature (1993) 12.74
Prevalence of ras gene mutations in human colorectal cancers. Nature (1987) 9.23
Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature (1994) 8.04
Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature (1994) 6.21
Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res (1993) 4.93
Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol (1994) 4.43
Genetic mapping of a locus predisposing to human colorectal cancer. Science (1993) 4.12
Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet (1995) 4.01
Closing in on a breast cancer gene on chromosome 17q. Am J Hum Genet (1992) 3.89
Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology (1993) 3.76
Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology (1996) 3.30
Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res (1994) 3.25
Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med (1998) 2.91
A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg (1985) 2.76
Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet (1996) 2.19
Mutations predisposing to hereditary nonpolyposis colorectal cancer. Adv Cancer Res (1997) 1.98
Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chromosomes Cancer (1992) 1.77
A CA repeat 30-70 KB downstream from the adenomatous polyposis coli (APC) gene. Nucleic Acids Res (1991) 1.69
Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells. J Biol Chem (1988) 1.43
CA repeat polymorphism at the D5S82 locus, proximal to adenomatous polyposis coli (APC). Nucleic Acids Res (1991) 1.29
DNA mismatch repair and cancer. Gastroenterology (1995) 1.25
Dinucleotide repeat polymorphism in the human DCC gene at chromosome 18q21. Hum Mol Genet (1992) 1.18
Estrogen-induced post-transcriptional modulation of c-myc proto-oncogene expression in human breast cancer cells. J Biol Chem (1988) 1.15
Tumor characteristics in colorectal cancer and their relationship to treatment and prognosis. Dis Colon Rectum (1987) 1.02
DNA mismatch repair and colorectal cancer. J Pathol (1998) 0.96
Clinico-pathological features and p53 expression in left-sided sporadic colorectal cancers with and without microsatellite instability. J Pathol (1996) 0.91
Molecular genetics of colon cancer. Cancer Metastasis Rev (1997) 0.88
ras and p53 in the prediction of survival in Dukes' stage B colorectal carcinoma. Clin Mol Pathol (1995) 0.83
Allelic loss of chromosome 17p, mutation of the p53 gene, and microsatellite instability in right- and left-sided colorectal cancer. Cancer (1996) 0.82
Cytoplasmic c-erbB-2 protein expression correlates with survival in Dukes' B colorectal carcinoma. Histopathology (1994) 0.82
The step-by-step development of epithelial cancer: from phenotype to genotype. Adv Cancer Res (1996) 0.81
The multistep process of colon carcinogenesis. Cytokines Mol Ther (1996) 0.81
Patterns of mutation in cancer cells. Cancer Surv (1996) 0.80
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
Crohn's disease in childhood. Arch Dis Child (1977) 2.50
Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease. Lancet (1978) 2.40
Comparative study: conventional cervical and ThinPrep Pap tests in a routine clinical setting. Cytopathology (2002) 2.39
Quantitative study of infarcted myocardium in cardiogenic shock. Br Heart J (1970) 2.29
Quality of colonoscopy performance among gastroenterology and surgical trainees: a need for common training standards for all trainees? Endoscopy (2011) 2.25
The relationship between cyclooxygenase-2 expression and colorectal cancer. JAMA (1999) 2.24
Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev (1999) 2.21
Coronary care for myocardial infarction in diabetics. Lancet (1974) 2.12
Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology (2005) 2.02
Reintroduction of gluten in adults and children with treated coeliac disease. Gut (1979) 1.97
Cultivar-specific avirulence and virulence functions assigned to avrPphF in Pseudomonas syringae pv. phaseolicola, the cause of bean halo-blight disease. EMBO J (2000) 1.76
Escherichia coli antibodies in patients with inflammatory bowel disease. Gut (1978) 1.73
Effects of a selective cyclo-oxygenase 2 inhibitor on colonic anastomotic and skin wound integrity. Br J Surg (2004) 1.68
Duration of colorectal cancer symptoms and survival: the effect of confounding clinical and pathological variables. Eur J Cancer (1997) 1.67
Observer variation and discriminatory value of biopsy features in inflammatory bowel disease. Gut (1994) 1.64
Peritoneal involvement in stage II colon cancer. Am J Clin Pathol (2003) 1.59
Bone remodeling indices and secondary hyperparathyroidism in celiac disease. Am J Gastroenterol (1996) 1.58
Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1. Neuroscience (2007) 1.55
Colonoscopic surveillance after curative resection for colorectal cancer. Br J Surg (1993) 1.47
Effect of neoadjuvant chemoradiotherapy on angiogenesis in oesophageal cancer. Br J Surg (2003) 1.46
The diagnosis of iron deficiency in patients with rheumatoid arthritis and anemia: an algorithm using simple laboratory measures. J Rheumatol (1996) 1.46
Mac387: its non-specificity as a tumour marker or marker of histiocytes. Histopathology (1991) 1.43
Classical galactosemia and mutations at the galactose-1-phosphate uridyl transferase (GALT) gene. Hum Mutat (1999) 1.37
Characterization of avrPphE, a gene for cultivar-specific avirulence from Pseudomonas syringae pv. phaseolicola which is physically linked to hrpY, a new hrp gene identified in the halo-blight bacterium. Mol Plant Microbe Interact (1995) 1.37
Vimentin: an evaluation of its role as a tumour marker. Histopathology (1987) 1.36
Tissue cytokine and chemokine expression in inflammatory bowel disease. Inflamm Res (2001) 1.33
The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol (1994) 1.32
The pattern of onset and spontaneous cessation of atrial fibrillation in man. Circulation (1970) 1.30
Clot lysis by gastric juice: an in vitro study. Gut (1989) 1.29
Long-term outcome following curative surgery for malignant large bowel obstruction. Br J Surg (1996) 1.28
Sequence variations in alleles of the avirulence gene avrPphE.R2 from Pseudomonas syringae pv. phaseolicola lead to loss of recognition of the AvrPphE protein within bean cells and a gain in cultivar-specific virulence. Mol Microbiol (1998) 1.26
Rectal IgE cells in inflammatory bowel disease. Gut (1979) 1.24
Myocardial infarction in diabetics. Q J Med (1975) 1.22
Biopsy of a biopsy: validation of immunoprofiling in gastric cancer biopsy tissue microarrays. Histopathology (2003) 1.19
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. Ann Oncol (2006) 1.18
Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer. J Pathol (2006) 1.17
Trial of combined intramuscular and intravenous lignocaine in prophylaxis of ventricular tachyarrhythmias. Lancet (1972) 1.17
Intensive care in the management of diabetic ketoacidosis. Lancet (1973) 1.17
Signal pathway profiling of epithelial and stromal compartments of colonic carcinoma reveals epithelial-mesenchymal transition. Oncogene (2007) 1.15
Focal loss of anterior horn cells in the cervical cord in motor neuron disease. Brain (1986) 1.13
Controlled trial of lignocaine in prophylaxis of ventricular arrhythmias complicating myocardial infarction. Lancet (1970) 1.13
Genetic basis of transferase-deficient galactosaemia in Ireland and the population history of the Irish Travellers. Eur J Hum Genet (1999) 1.12
Inflammatory bowel disease in West Indians. Br Med J (1976) 1.11
Screening for asymptomatic colorectal cancer. BMJ (1997) 1.10
KP-1: not a specific marker. Staining of 137 sarcomas, 48 lymphomas, 28 carcinomas, 7 malignant melanomas and 8 cystosarcoma phyllodes. Virchows Arch (1994) 1.09
Proliferation indexes--a comparison between cutaneous basal and squamous cell carcinomas. J Clin Pathol (1996) 1.08
Human IgG antibody profiles differentiate between symptomatic patients with and without colorectal cancer. Gut (2010) 1.08
T cell depletion in untreated adult coeliac disease. Gut (1976) 1.08
The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer. Colorectal Dis (2014) 1.08
C-erbB-2 immunostaining: problems with interpretation. J Clin Pathol (1994) 1.06
Low-grade fibromyxoid sarcoma. Histopathology (1990) 1.04
Prognosis of elderly patients with large bowel cancer. Br J Surg (1994) 1.03
Formalin-fixed paraffin-embedded clinical tissues show spurious copy number changes in array-CGH profiles. Clin Genet (2007) 1.02
Identifying stage B colorectal cancer patients at high risk of tumor recurrence and death. Dis Colon Rectum (1997) 1.02
Serial analysis of gene expression identifies putative metastasis-associated transcripts in colon tumour cell lines. Br J Cancer (2000) 1.02
Percutaneous endoscopic gastrostomy: 5 years of clinical experience on 238 patients. Ir Med J (2003) 1.01
Improved wound healing with a modified electrosurgical electrode. Br J Plast Surg (1991) 1.01
Embolotherapy for massive upper gastrointestinal haemorrhage secondary to metastatic renal cell carcinoma: report of three cases. Gut (1995) 1.00
Soft tissue and visceral sarcomas in Irish patients. A preliminary report from the Dublin Soft Tissue Tumour Panel. Ir J Med Sci (1991) 1.00
Intestinal bile acid malabsorption in cystic fibrosis. Gut (1993) 1.00
Regulation of ion transport by histamine in human colon. Eur J Pharmacol (1995) 0.99
Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression. Histopathology (2007) 0.98
CD4+ CD8+ and CD8alpha+ beta- T lymphocytes in human small intestinal lamina propria. Eur J Gastroenterol Hepatol (1998) 0.98
Staining for factor VIII related antigen and Ulex europaeus agglutinin I (UEA-I) in 230 tumours. An assessment of their specificity for angiosarcoma and Kaposi's sarcoma. Histopathology (1986) 0.98
Cancer and mutant DNA in blood plasma. Lancet (1996) 0.98
Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer. Lancet (1994) 0.98
The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study. Br J Cancer (2011) 0.97
The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue. Br J Cancer (2011) 0.97
Remission induction in refractory Crohns disease using a high calorie whole diet. JPEN J Parenter Enteral Nutr (1989) 0.97
CD44V6 in gastric carcinoma: a marker of tumor progression. Appl Immunohistochem Mol Morphol (2001) 0.96
Phenotypic characterization of cognition and social behavior in mice with heterozygous versus homozygous deletion of catechol-O-methyltransferase. Neuroscience (2008) 0.96
The existence of inflammatory bowel lesions in gluten-sensitive enteropathy. Postgrad Med J (1979) 0.96
Report of the task force on the implications for darkly pigmented intact skin in the prediction and prevention of pressure ulcers. Adv Wound Care (1996) 0.96
Altered gastrointestinal immune response in sarcoidosis. Gut (1988) 0.95
Prognostic significance of p53 abnormalities in colorectal carcinoma detected by PCR-SSCP and immunohistochemical analysis. J Pathol (1996) 0.95
Synovial infection with Mycobacterium kansasii. Ann Rheum Dis (1984) 0.95
Omeprazole provides quicker symptom relief and duodenal ulcer healing than ranitidine. Gastroenterology (1990) 0.95
Abdominal aortic aneurysm in the Irish population: a familial screening study. Br J Surg (1995) 0.95
Crohn's colitis and sarcoidosis. Postgrad Med J (1986) 0.94
Gastric lesion in dermatitis herpetiformis. Gut (1976) 0.94
Expression of Cathepsin B and L antigen and activity is associated with early colorectal cancer progression. Eur J Cancer (2004) 0.93
Potassium balance during treatment of diabetic ketoacidosis with special reference to the use of bicarbonate. Lancet (1972) 0.93
Plasmablastic lymphoma presenting as a paravertebral mass in a patient with Crohn's disease after immunosuppressive therapy. J Clin Pathol (2007) 0.93
Telomerase activity in proximal and distal gastric neoplastic and preneoplastic lesions using immunohistochemical detection of hTERT. Dig Liver Dis (2005) 0.93
Is impaired baroreflex sensitivity a predictor or cause of sudden death in insulin-dependent diabetes mellitus? Diabet Med (1997) 0.93
Anti-alpha 1-antichymotrypsin staining of 194 sarcomas, 38 carcinomas, and 17 malignant melanomas. Its lack of specificity as a tumour marker. Am J Surg Pathol (1987) 0.93
Multivariate analysis of MLH1 c.1664T>C (p.Leu555Pro) mismatch repair gene variant demonstrates its pathogenicity. Fam Cancer (2013) 0.93
Conservation of behavioural topography to dopamine D1-like receptor agonists in mutant mice lacking the D1A receptor implicates a D1-like receptor not coupled to adenylyl cyclase. Neuroscience (1999) 0.92
Nuclear oxidative damage correlates with poor survival in colorectal cancer. Br J Cancer (2008) 0.92
Flow cytometric analysis of Clostridium difficile adherence to human intestinal epithelial cells. J Med Microbiol (2001) 0.92
Modification of the mandibular ramus sagittal split osteotomy. Oral Surg Oral Med Oral Pathol (1987) 0.92